MICA and hepatocellular carcinoma: Therefore, besides the direct efficacy of HDACi chemotherapy, the eventual elimination of anti-apoptotic HCC cells by NK cells via targeting MICA could be expected to ultimately achieve efficient chemoimmunotherapy (i.e., the combination of targeted chemotherapy and immunotherapy).